News > Bharat Biotech’s intranasal Covid-19 vaccine to cost Rs 800 for private, 325 for govt hospitals

Bharat Biotech’s intranasal Covid-19 vaccine to cost Rs 800 for private, 325 for govt hospitals

iNCOVACC is the world’s first intranasal vaccine for COVID to receive approval for the primary two-dose schedule, and as a heterologous booster dose. Earlier this month, Bharat Biotech received approval from the Central Drugs Standard Control Organisation (CDSCO) for the use of heterologous booster doses of iNCOVACC.